Also trades as: GLAND.BO (BSE) · $vol 6M

₹2,895.10 ($30.07)

+20.70 (+0.72%)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 50 · ₹472.8B mcap · 79M float · 0.852% daily turnover

Revenue

$64.3B +14.5% ▲

5Y CAGR: +13.2%

Gross Profit

$19.3B -38.7% ▼

5Y CAGR: +0.8%

Operating Income

$12.1B -30.6% ▼

5Y CAGR: -3.2%

Net Income

$10.3B +47.1% ▲

5Y CAGR: +0.6%

EPS (Diluted)

$62.28 +46.9% ▲

5Y CAGR: -0.2%

EBITDA

$19.2B +56.0% ▲

5Y CAGR: +8.1%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$44.0B	$36.2B	$56.6B	$56.2B	$64.3B
YoY Growth	+27.1%	-17.6%	+56.3%	-0.9%	+14.5%
Cost of Revenue	$22.5B	$18.6B	$25.5B	$24.6B	$45.0B
Gross Profit	$21.5B	$17.7B	$31.1B	$31.5B	$19.3B
Gross Margin	48.9%	48.7%	54.9%	56.2%	30.0%
R&D Expenses	$2.3B	$2.0B	$0	$0	$2.2B
SG&A Expenses	$3.4B	$4.1B	$12.9B	$14.2B	$5.0B
Operating Expenses	$5.7B	$6.1B	$12.9B	$14.2B	$7.3B
Operating Income	$15.8B	$11.6B	$18.2B	$17.4B	$12.1B
Operating Margin	36.0%	31.9%	32.2%	30.9%	18.8%
Interest Expense	$52M	$74M	$262M	$240M	$333M
Income Before Tax	$16.2B	$10.5B	$11.3B	$10.6B	$14.6B
Tax Expense	$4.1B	$2.7B	$3.6B	$3.6B	$4.4B
Net Income	$12.1B	$7.8B	$7.7B	$7.0B	$10.3B
Net Margin	27.5%	21.5%	13.6%	12.4%	16.0%
EPS (Diluted)	$73.64	$47.43	$46.89	$42.40	$62.28
EBITDA	$15.1B	$10.3B	$13.0B	$12.3B	$19.2B
Shares Outstanding	165M	165M	165M	165M	165M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$14.0B	$14.1B	$13.8B	$14.2B	$15.1B	$14.9B	$17.0B	$17.4B
Cost of Revenue	$6.1B	$6.2B	$5.2B	$7.1B	$10.8B	$11.0B	$11.6B	$11.6B
Gross Profit	$7.9B	$7.8B	$8.7B	$7.1B	$4.3B	$3.9B	$5.3B	$5.8B
Gross Margin	56.4%	55.8%	62.6%	50.0%	28.5%	26.3%	31.4%	33.2%
R&D Expenses	$489M	$493M	$437M	$1.4B	$460M	$614M	$650M	$506M
SG&A Expenses	$3.6B	$3.3B	$3.4B	$3.9B	$1.2B	$1.2B	$1.4B	$1.2B
Operating Expenses	$4.0B	$3.8B	$3.9B	$5.3B	$1.6B	$1.8B	$2.1B	$1.7B
Operating Income	$3.9B	$4.1B	$4.8B	$1.8B	$2.7B	$2.1B	$3.3B	$4.0B
Operating Margin	27.6%	28.9%	34.7%	12.7%	17.7%	14.0%	19.3%	23.2%
Interest Expense	$56M	$61M	$228M	$74M	$115M	$78M	$39M	$100M
Income Before Tax	$2.2B	$2.6B	$3.0B	$2.9B	$3.1B	$2.8B	$3.6B	$5.1B
Tax Expense	$745M	$932M	$946M	$1.0B	$973M	$1.0B	$1.0B	$1.4B
Net Income	$1.4B	$1.6B	$2.0B	$1.9B	$2.2B	$1.8B	$2.6B	$3.7B
Net Margin	10.3%	11.6%	14.8%	13.1%	14.3%	12.4%	15.4%	21.0%
EPS (Diluted)	$8.73	$9.93	$12.42	$11.32	$13.08	$11.15	$15.87	$22.23
EBITDA	$2.6B	$3.0B	$3.4B	$3.2B	$4.1B	$4.0B	$4.7B	$6.2B
Shares Outstanding	165M	165M	165M	165M	165M	165M	165M	165M

GLAND.NS NSE